Rhumbline Advisers Amneal Pharmaceuticals, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 224,389 shares of AMRX stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
224,389
Previous 233,217
3.79%
Holding current value
$1.87 Million
Previous $1.48 Million
26.08%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding AMRX
# of Institutions
185Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$181 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$122 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$103 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$93.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$89.2 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.26B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...